Decongestant Effect, Timing of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold

A Double-Blind, Randomized, Parallel Group, Placebo Controlled Study, Evaluating the Decongestant Effect, Time to Onset, Duration of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold

The aim of this study is to characterize the time profile of the decongestant properties of xylometazoline and to investigate its effect on sleep, general well-being and smell/taste.

Inclusion Criteria:

• Over 18 years
• Have had moderate common cold symptoms for less than 36 hours.

Exclusion Criteria:

• Congested/runny nose for more than two continuous weeks in the previous 12 months
• Deviated septum or nasal polyps
• Recent use of antibiotics
• Recent sinusitis

Other protocol-defined inclusion/exclusion criteria may apply.